Greenwich LifeSciences, Inc. - COM (GLSI)

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
827,405
Share change
+156,722
Total reported value
$11,410,584
Price per share
$13.79
Number of holders
26
Value change
+$2,160,542
Number of buys
14
Number of sells
7

Institutional Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q1 2023

As of 31 Mar 2023, Greenwich LifeSciences, Inc. - COM (GLSI) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 827,405 shares. The largest 10 holders included VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, HRT FINANCIAL LP, and JANE STREET GROUP, LLC. This page lists 26 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.